A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives
2017
Journal of Immunology Research
Pseudophenomena, that is, imaging alterations due to therapy rather than tumor evolution, have an important impact on the management of glioma patients and the results of clinical trials. RANO (response assessment in neurooncology) criteria, including conventional MRI (cMRI), addressed the issues of pseudoprogression after radiotherapy and concomitant chemotherapy and pseudoresponse during antiangiogenic therapy of glioblastomas (GBM) and other gliomas. The development of cancer immunotherapy
doi:10.1155/2017/5813951
pmid:28512646
pmcid:PMC5415864
fatcat:p6yb4tjcwvdflornpvwpuxum4e